2015
DOI: 10.1016/j.juro.2015.02.767
|View full text |Cite
|
Sign up to set email alerts
|

Mp39-17 a Novel Combinatorial Therapy in Renal Cell Carcinoma: Silencing Semaphorin 3c in Combination With Sunitinib

Abstract: and also significantly higher in RCC samples as compared to normal kidney samples (p<0.0001). The higher expression of versican was significantly correlated with high stage disease and systematic metastasis (p<0.05). When the expression level of the versican mRNA transcript was divided into 2 groups based on median values, higher expression was significantly associated with overall survival (OS) after a radical nephrectomy (p¼0.0235). After transfection of versican siRNA, cell viability, migration, and invasio… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles